About
Ginger Liau is a partner on the Bio + Health team focused on biotech. She leads business development for the a16z life sciences portfolio.
Prior to joining Andreessen Horowitz, Ginger worked at Alnylam Pharmaceuticals where she held a variety of positions across the business. She worked as an RNA chemist before moving into strategy and operations roles in business planning, program management, and investor relations.
Ginger graduated summa cum laude from Vanderbilt University where she majored in Chemistry and Math. She earned her MBA from Stanford Graduate School of Business.
Latest Content by Ginger
The History and Future of CAR T with Bruce Levine
Field Notes from the frontlines of cell & gene therapy; AlphaFold advances; Healthcare price transparency; Power law for profs; and more
Ginger on X
Join the conversationWant More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.
Want More Bio+Health?
Insights, analysis, and additional reading on bio and health, and how both are shaping our future.